Company profile for CollPlant

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing. Our revolutionary plant-based technology is the only commercially viable technology for mass production of recombinant human Type I collagen (rhCollagen), which is identical to the collagen produced by the human body. This makes our rhCollagen the ideal building block fo...
CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing. Our revolutionary plant-based technology is the only commercially viable technology for mass production of recombinant human Type I collagen (rhCollagen), which is identical to the collagen produced by the human body. This makes our rhCollagen the ideal building block for regenerative medicine. Leveraging on the unique properties of rhCollagen and biomaterial know-how, we are developing a pipeline of products aimed at 3D bioprinting of tissues and organs and medical aesthetics.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Israel
Address
Address
4 Oppenheimer Street P.O. Box 4132 Rehovot 7670104
Telephone
Telephone
+972 73 2325600
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/collplant-biotechnologies-announces-date-for-2025-third-quarter-financial-results-302618450.html

PR NEWSWIRE
18 Nov 2025

https://www.prnewswire.com/news-releases/collplant-expands-its-rhcollagen-distribution-capabilities-in-the-united-states-and-canada-302595229.html

PR NEWSWIRE
27 Oct 2025

https://www.prnewswire.com/news-releases/collplants-rhcollagen-based-bioink-demonstrates-strong-performance-compared-to-matrigel-in-study-conducted-by-technion--israel-institute-of-technology-302588881.html

PR NEWSWIRE
20 Oct 2025

https://www.prnewswire.com/news-releases/first-in-kind-fully-humanized-3d-bioprinted-human-skin-model-developed-by-mayo-clinic-researchers-using-collplants-rhcollagen-based-bioink-302585959.html

PR NEWSWIRE
16 Oct 2025

https://www.prnewswire.com/news-releases/collplant-biotechnologies-announces-positive-results-from-non-clinical-studies-of-its-photocurable-regenerative-dermal-and-soft-tissue-filler-302570620.html

PR NEWSWIRE
30 Sep 2025

https://www.prnewswire.com/news-releases/collplant-expands-the-distribution-of-its-vergenixstr-product-in-europe-302556086.html

PR NEWSWIRE
15 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty